A West Virginia University legal scholar says current laws may be giving manufacturers of biologic drugs, like antibodies and flu vaccines, too much in the way of legal protections before copycat versions can be sold when compared with traditional small-molecule drugs, including antibiotics and steroids.

Medical Xpress

Legal scholar makes case for equal protection among different medication classes

A West Virginia University legal scholar says biologic drugs like the flu vaccine are afforded a lengthy period of legal protection before copycat versions can be sold. In contrast, small-molecule drugs like antibiotics and steroids get far less time, and that may unfairly benefit biologic manufacturers, according to Sean Tu with the WVU College of Law.

Newswise

Charlottesville

Albemarle County

Virginia

United States

A West Virginia University legal scholar says current laws may be giving manufacturers of biologic drugs, like antibodies and flu vaccines, too much in the way of legal protections before copycat versions can be sold when compared with traditional small-molecule drugs, including antibiotics and steroids.In an article in the Journal of the American Medical Association, Sean Tu, professor at the WVU College of Law, looks at the Food and Drug Admin…

West Virginia University

Morgantown

Monongalia County

West Virginia

WVU legal scholar makes case for equal protection among different medication classes

A recent study reignited a pivotal debate surrounding the legal protections granted to biologic drugs in comparison to small-molecule drugs, highlighting a significant disparity in the exclusivity periods and the implications for both manufacturers and healthcare costs. The findings, authored by Sean Tu, a legal scholar at West Virginia University, reveal that the current framework in the United States may tilt the playing field unjustly in favo…

Scienmag: Latest Science and Health News

WVU Legal Scholar Advocates for Equal Protection Across Diverse Medication

A West Virginia University legal scholar says current laws may be giving manufacturers of biologic drugs, like antibodies and flu vaccines, too much in the way of legal protections before copycat versions can be sold when compared with traditional small-molecule drugs, including antibiotics and steroids. In an article in the Journal of the American Medical […]

Legal scholar makes case for equal protection among different medication classes

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics